Published in

Nature Research, Nature Communications, 1(13), 2022

DOI: 10.1038/s41467-022-30050-y

Links

Tools

Export citation

Search in Google Scholar

The genomic and transcriptional landscape of primary central nervous system lymphoma

Journal article published in 2022 by Josefine Radke, Seq Consortium]Siebert R. [Icgc Mmml, Seq Consortium]Wagner S. [Icgc Mmml, Seq Consortium]Staib P. [Icgc Mmml, Seq Consortium]Stilgenbauer S. [Icgc Mmml, Seq Consortium]Zenz T. [Icgc Mmml, Seq Consortium]Szczepanowski M. [Icgc Mmml, Seq Consortium]Vater I. [Icgc Mmml, Seq Consortium]Wagener R. [Icgc Mmml, Seq Consortium]Sungalee S. [Icgc Mmml, Seq Consortium]Haake A. [Icgc Mmml, Seq Consortium]Richter J. [Icgc Mmml, Seq Consortium]Richter G. [Icgc Mmml, Seq Consortium]Lawerenz C. [Icgc Mmml, Seq Consortium]Kerssemakers J. [Icgc Mmml and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractPrimary lymphomas of the central nervous system (PCNSL) are mainly diffuse large B-cell lymphomas (DLBCLs) confined to the central nervous system (CNS). Molecular drivers of PCNSL have not been fully elucidated. Here, we profile and compare the whole-genome and transcriptome landscape of 51 CNS lymphomas (CNSL) to 39 follicular lymphoma and 36 DLBCL cases outside the CNS. We find recurrent mutations in JAK-STAT, NFkB, and B-cell receptor signaling pathways, including hallmark mutations in MYD88 L265P (67%) and CD79B (63%), and CDKN2A deletions (83%). PCNSLs exhibit significantly more focal deletions of HLA-D (6p21) locus as a potential mechanism of immune evasion. Mutational signatures correlating with DNA replication and mitosis are significantly enriched in PCNSL. TERT gene expression is significantly higher in PCNSL compared to activated B-cell (ABC)-DLBCL. Transcriptome analysis clearly distinguishes PCNSL and systemic DLBCL into distinct molecular subtypes. Epstein-Barr virus (EBV)+ CNSL cases lack recurrent mutational hotspots apart from IG and HLA-DRB loci. We show that PCNSL can be clearly distinguished from DLBCL, having distinct expression profiles, IG expression and translocation patterns, as well as specific combinations of genetic alterations.